Skip to main content
. 2024 Dec 15;16(12):4650–4662. doi: 10.4251/wjgo.v16.i12.4650

Figure 2.

Figure 2

Nomogram constructed based on independent risk factors for predicting 1-, 2-, and 3-year overall survival in patients with hepatocellular carcinoma. GAR: γ-glutamyl transferase to albumin ratio; PVTT: Portal vein tumor thrombus.